Rafael Holdings Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Rafael Holdings Inc.
Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.
/ 
Frequently asked questions
To buy Rafael Holdings Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Rafael Holdings Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Rafael Holdings Inc. is RFL:xnys. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Rafael Holdings Inc. has its primary listing on New York Stock Exchange. You can trade Rafael Holdings Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Rafael Holdings Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Rafael Holdings Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Rafael Holdings Inc..